Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients with Cervical Dystonia in the US
Objective: To compare health care resource utilization (HCRU) and costs among patients with cervical dystonia (CD) in the US who are persistent vs nonpersistent with…Using wearable wireless technology to understand the natural history of adrenomyeloneuropathy in both clinic and home settings: 1-year follow-up in the CYGNET study
Objective: To assess the feasibility of using wearable wireless motion sensors to quantify disease progression in men with adrenomyeloneuropathy (AMN) enrolled in the CYGNET natural…Inhibitory and facilitatory alterations in prodromal and de novo Parkinson’s disease
Objective: The aim of this study was to detect alterations within GABAergic, glutamatergic and cholinergic circuitries in Parkinson’s Disease (PD) patients, including de Novo PD…Botulinum toxin injections for lingual protrusion dystonia: a review of the muscle target and dosage
Objective: The aim of our study was to perform a literature review about the botulinum toxin types, their dosage and muscle target in the treatment…Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls
Objective: To investigate the influence of a standardized, placebo-controlled administration of levodopa on cerebral bioenergetics in patients with Parkinson’s disease (PwPD) and healthy controls (HCs).…Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension
Objective: To determine whether orthostatic hypotension (OH) and/or supine hypertension (SH) are longitudinally associated with cognitive decline in Parkinson disease (PD). Background: Cognitive impairment is…Multiple methods to improve recruitment, enrollment, and retention of study participants for validation of the Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)
Objective: Describe multiple methods used to recruit, enroll and retain participants to validate the FXTAS-RS. Background: A clinical outcome assessment (COA) must be developed to…The Role of Adaptive Immunity caused by α-synuclein Recognition Specific Sequence Peptide on the Onset of Parkinson’s Disease Pathogenesis
Objective: We investigated whether α-synuclein-derived peptides (recognized specific sequence in α-synuclein) can drive T-cell response and evaluated the neurotoxicity of α-synuclein peptide-specific T-cell in Parkinson’s…Potentially inappropriate medication useage among patients newly diagnosed with dementia with Lewy bodies
Objective: Investigate the use of potentially inappropriate medications (PIM) among patients newly diagnosed with dementia with Lewy bodies (DLB). Background: PIM, including anticholinergics, are associated…Review of NPO status on admitted PD patient outcomes
Objective: To characterize the incidence and severity of outcomes for PD patients admitted to the hospital who miss doses of their medication. Background: PD is…
- « Previous Page
- 1
- …
- 91
- 92
- 93
- 94
- 95
- …
- 186
- Next Page »